Question 22

A company must obtain a written authorization from the proposed insured prior to conducting an HIV-related test.

Obtaining a written authorization from the proposed insured is essential to ensure that the individual consents to the testing process, adhering to legal and ethical standards regarding personal health information.

A) Obtain a written authorization from the proposed insured.

This option is correct as it emphasizes the necessity of consent from the individual undergoing the HIV-related test. In many jurisdictions, it is a legal requirement to have written consent to protect the rights and privacy of the insured.

B) Provide notification to the beneficiary.

While notifying the beneficiary may be important in some contexts, it does not address the requirement for consent prior to testing. This option is incorrect because it does not fulfill the primary obligation of obtaining authorization from the individual being tested.

C) Notify the Department of Health.

Notifying the Department of Health is not a prerequisite for conducting an HIV-related test. This option is incorrect as it does not pertain to the individual's consent and privacy rights, which are paramount before any testing is performed.

D) Obtain the approval from the applicant's designated doctor.

This option incorrectly suggests that a doctor's approval is necessary before conducting an HIV test. While a healthcare provider may play a role in the testing process, the fundamental requirement is the written consent from the proposed insured, making this option incorrect.

Conclusion

Obtaining written authorization from the proposed insured is critical for legal compliance and ethical practice in conducting HIV-related tests. The other options fail to address the necessity of direct consent from the individual, which is the core requirement prior to any testing. Thus, Option A stands out as the only correct choice in this context.